Skip to content
Search

Latest Stories

PM urged to protect healthcare teams from new Covid-19 variants

Various healthcare organisations representing community pharmacies, doctors, nurses, paramedics, and other healthcare professions have called upon prime minister Boris Johnson to make a quick intervention to protect all healthcare teams from the new variants of Covid-19.

In a letter to the prime minister, various healthcare organisations, including the Royal Pharmaceutical Society, have written that health and care workers are up to four times greater risk of developing and dying from Covid-19 than the general public.


“However, measures to reduce airborne spread in high-risk health and care settings, which are mission-critical to the pandemic response, have thus far been inadequate. Current policies continue to emphasise the importance of fomite, droplet and direct spread but do not properly address airborne transmission,” the letter said.

“We believe that given the rapid emergence and evolution of new variants of concern, a change in approach must be implemented at speed to protect patients and staff consistently across the UK,” the letter urged.

The letter further urged the Prime Minister to ensure that

  • all health and care providers assess and improve the quality of ventilation in all settings to reduce the risks of airborne spread
  • amend the UK IPC guidance to reflect and increase the level of respiratory protection as a precautionary principle for all health and care workers providing care to people with known or suspected Covid-19, or as a result of local risk assessment
  • update all guidance to reflect the evidence on airborne transmission, ensuring representation from a truly multidisciplinary range of experts including engineering, aerosol science, occupational health, infection prevention and control and behavioural science in addition to stakeholders such as Royal Colleges, professional and scientific bodies and trade unions
  • collect and publish consistent data on health care workers who have contracted Covid-19 from likely occupational exposure so we can identify health and care settings where staff are most affected and target responses to address this.

The organisations have also urged the government to publish all scientific evidence on airborne transmission in health and care settings and undertake research to fill any knowledge gaps.

RPS president Sandra Gidley said: “Pharmacists and pharmacy teams are on the frontline of the Covid-19 pandemic and have shown enormous dedication to supporting patient care under the most challenging circumstances.

“As our understanding of Covid-19 variants evolves, it’s vital that guidance and support keeps pace so that all health and care workers receive the protection they need.”

More For You

GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less
Community Pharmacy Scotland secures £10m reimbursement uplift amid ongoing negotiations

Negotiations continue on the Global Sum element of remuneration.

Getty Images

Community Pharmacy Scotland secures £120m reimbursement deal for 2025/26

Community Pharmacy Scotland (CPS) has accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

The agreement marks the first phase of ongoing negotiations surrounding community pharmacy funding for the upcoming financial year.

Keep ReadingShow less